Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2015 | Manzo Pharmaceuticals Inc. Announces New Product Somnaid Release | CI |
2015 | Manzo Pharmaceuticals Announces Positive Results from Laboratory Study of Lacto-Freedom Probiotic | CI |
Sales 2003 | 3M 250M | Sales 2004 | 3.07M 256M | Capitalization | 8.07K 672K |
---|---|---|---|---|---|
Net income 2003 | -3M -250M | Net income 2004 | -4M -333M | EV / Sales 2003 | - |
Net Debt 2003 | 7.3 608.06 | Net Debt 2004 | 6.51 542.29 | EV / Sales 2004 | - |
P/E ratio 2003 |
-0.73
x | P/E ratio 2004 |
-0.42
x | Employees | 12 |
Yield 2003 * |
-
| Yield 2004 |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.1K | |
+10.23% | 9.11B | |
-10.76% | 5.21B | |
+53.60% | 4.83B | |
+12.50% | 4.09B | |
-21.42% | 2.35B | |
+14.01% | 2.32B | |
+19.51% | 2.27B | |
-29.65% | 2.19B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- MNZO Stock